Our company has initiated an advanced industry-academia collaborative project with the Institute of Medical Science at the University of Tokyo.
As we reported in a recent press release, we are engaging in multifaceted cooperation and collaboration on vaccine research and analysis with the Institute of Medical Science at the University of Tokyo.
In this initiative, we will conduct a comprehensive analysis of cancer pathogenesis mechanisms (both the mechanisms and progression of cancer) and will collaborate on the study of analyzing cancer information in the blood at early stages.
This research is related to the early detection of cancer and aims to contribute to cancer prevention and early medical treatment.